Standout Papers

Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice... 2019 2026 2021 2023 220
  1. Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice (2019)
    Qinyu Wang, Guomin Hu et al. British Journal of Pharmacology

Immediate Impact

35 standout
Sub-graph 1 of 18

Citing Papers

Macrophage plasticity: signaling pathways, tissue repair, and regeneration
2024 Standout
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
2024 Standout
2 intermediate papers

Works of Guomin Hu being referenced

Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice
2019 Standout

Author Peers

Author Last Decade Papers Cites
Guomin Hu 178 73 26 129 11 371
Lu Yang 182 38 21 97 17 381
Santosh Kumar Goru 205 81 11 63 15 401
Almesh Kadakol 201 86 16 57 15 397
Jiaqi Cheng 181 26 27 197 14 411
Fengjiao Hu 167 45 21 124 15 353
Teresa Navarra 90 61 27 72 15 383
Wenlong Zhang 132 26 33 132 16 369
Shengliang Xin 158 24 36 234 12 393
Sha Hu 160 22 25 173 10 324
Bojan Jorgačević 108 30 41 175 18 380

All Works

Loading papers...

Rankless by CCL
2026